Clinical evaluation of roxithromycin in patients with acne

Journal of International Medical Research

Volumn 24, Issue 1, 1996, Pages 109-114

  Akamatsu, H ^a   Nishijima, S ^a   Akamatsu, M ^a   Kurokawa, I ^a   Asada, Y ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

Acne; Roxithromycin; Therapy

Indexed keywords

ROXITHROMYCIN;

ACNE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PROPIONIBACTERIUM ACNES;

EID: 0030066335     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/030006059602400114     Document Type: Article

References (21)

1. Kurokawa I, Nishijima S, Asada Y: The antibiotic susceptibility of Propionibacterium acnes: a 15-year bacteriological study and retrospective evaluation. J Dermatol (Tokyo) 1988; 15: 149-154.
2. Miyachi Y, Yoshioka A, Imamura S, et al: Effect of antibiotics on the generation of reactive oxygen species. J Invest Dermatol 1986; 86: 449-453.
3. Akamatsu H, Asada M, Komura J, et al: Effect of doxycycline on the generation of reactive oxygen species: a possible mechanism of action of acne therapy with doxycycline. Acta Derm Venereol (Stockh) 1992; 72: 178-179.
4. Akamatsu H, Nishijima S, Takahashi M, et al: Effects of subminimal inhibitory concentrations of erythromycin, tetracycline, clindamycin, and minocycline on the neutrophil chemotactic factor production in Propionibacterium acnes bio-types 1-5. J Dermatol (Tokyo) 1991; 18: 247-251.
5. Akamatsu H, Niwa Y, Kurokawa I, et al: Effects of subminimal inhibitory concentrations of minocycline on neutrophil chemotactic factor production in comedonal bacteria, neutrophil phagocytosis and oxygen metabolism. Arch Dermatol Res 1991; 283: 524-528.
6. Akamatsu H, Kurokawa I, Nishijima S, et al: Inhibition of neutrophil chemotactic factor production in comedonal bacteria by subminimal inhibitory concentrations of erythromycin. Dermatology 1992; 185: 41-43.
7. Cunliffe WJ: Side-effects of acne therapy. In: Acne (Marks R, ed). London: Martin Dunitz, 1989; pp 288-324.
8. Jones RN, Barry AL, Thornserry C: In vitro evaluation of three new macrolide antimicrobial agents, RU 28965, RU 29065, RU 29702, and comparisons with other orally administered drugs. Antimicrob Agents Chemother 1983; 24: 209-215.
9. Barlam T, Neu HC: In vitro comparison of the activity of RU 28965, a new macrolide, with that of erythromycin against aerobic and anaerobic bacteria. Antimicrob Agents Chemother 1984; 25: 529-531.
10. Chantot JF, Bryskier A, Case JC: Antibacterial activity of roxithromyc In: a laboratory evaluation. J Antibiotics 1986; 39: 660-668.
11. Baird-Parker AC: Staphylococcus. In: Bergey's Manual of Determinative Bacteriology, 8th Ed (Buchanan RE, Gibbons NE, eds). Baltimore: Williams & Wilkins, 1974; pp 483-489.
12. Kishishita M, Ushijima T, Ozaki Y, et al: New medium for isolating Propionibacteria and its application to assay of normal flora of human facial skin. Appl Environ Microbial 1980; 40: 1100-1105.
13. Goto S, Kawakita T, Kozaki N, et al: Methods for determination of minimum inhibitory concentration (MIC). Chemotherapy 1981; 29: 76-79.
14. Kosaki N, Ueno K, Goto S, et al: Agar dilution procedure for antimicrobial susceptibility testing of anaerobic bacteria. Chemotherapy 1972; 27: 559-561.
15. Esterly NB, Furey ML, Flanagan LE: The effect of antimicrobial agents on chemotaxis. J Invest Dermatol 1978; 70: 51-55.
16. Esterly NB, Koransky JS, Furey NL, et al: Neutrophil chemotaxis in patients with acne receiving tetracycline therapy. Arch Dermatol 1984; 120: 1308-1313.
17. Martin RR, Warr JA, Couch RB, et al: Effects of tetracycline on leukotaxis. J Infect Dis 1974; 129: 110-116.
18. Webster GF, Leyden JJ: Mechanisms of Propionibacterium acnes mediated inflammation in acne vulgaris. Semin Dermatol 1982; 1: 299-304.
19. Basler RSW: Minocycline-related hyperpigmentation. Arch Dermatol 1985; 121: 606-608.
20. Eady EA, Cove JH, Holland KT, et al: Erythromycin resistant Propionibacteria in antibiotic-treated acne patients: association with therapeutic failure. Br J Dermatol 1989; 121: 51-57.
21. Leyden JJ, McGinley KJ, Cavalieri S, et al: Propionibacterium acnes resistance to antibiotics in acne patients. J Am Acad Dermatol 1983; 8: 41-45.